NICE is implementing changes to its technology appraisal processes in what is described as a bid to increase its capacity and output, while also enabling faster patient access, and simplifying…

One of the wins to come out of the recent NICE methods review, according to Industry and others in the Life Sciences ecosystem, was the introduction of the severity modifier.[i]…

Last week saw the first hints of the new Health Secretary’s approach to an NHS increasingly used to setting its own agenda. Like so many other public services, political management of the…

As any experienced market access professional will tell you, securing access to a new medicine is rarely as simple as just submitting a dossier to a national body and waiting…